Literature DB >> 26003521

Myeloperoxidase formation of PAF receptor ligands induces PAF receptor-dependent kidney injury during ethanol consumption.

Calivarathan Latchoumycandane1, Laura E Nagy2, Thomas M McIntyre3.   

Abstract

Cytochrome P450 2E1 (CYP2E1) induction and oxidative metabolism of ethanol in hepatocytes inflame and damage liver. Chronic ethanol ingestion also induces kidney dysfunction, which is associated with mortality from alcoholic hepatitis. Whether the kidney is directly affected by ethanol or is secondary to liver damage is not established. We found that CYP2E1 was induced in kidney tubules of mice chronically ingesting a modified Lieber-deCarli liquid ethanol diet. Phospholipids of kidney tubules were oxidized and fragmented in ethanol-fed mice with accumulation of azelaoyl phosphatidylcholine (Az-PC), a nonbiosynthetic product formed only by oxidative truncation of polyunsaturated phosphatidylcholine. Az-PC stimulates the inflammatory PAF receptor (PTAFR) abundantly expressed by neutrophils and kidney tubules, and inflammatory cells and myeloperoxidase-containing neutrophils accumulated in the kidneys of ethanol-fed mice after significant hysteresis. Decreased kidney filtration and induction of the acute kidney injury biomarker KIM-1 in tubules temporally correlated with leukocyte infiltration. Genetic ablation of PTAFR reduced accumulation of PTAFR ligands and reduced leukocyte infiltration into kidneys. Loss of this receptor in PTAFR(-/-) mice also suppressed oxidative damage and kidney dysfunction without affecting CYP2E1 induction. Neutrophilic inflammation was responsible for ethanol-induced kidney damage, because loss of neutrophil myeloperoxidase in MPO(-/-) mice was similarly protective. We conclude that ethanol catabolism in renal tubules results in a self-perpetuating cycle of CYP2E1 induction, local PTAFR ligand formation, and neutrophil infiltration and activation that leads to myeloperoxidase-dependent oxidation and damage to kidney function. Hepatocytes do not express PTAFR, so this oxidative cycle is a local response to ethanol catabolism in the kidney.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Acute kidney injury; Free radicals; Inflammation; Kidney; Oxidized phospholipids; PAF receptor; Reactive oxygen species

Mesh:

Substances:

Year:  2015        PMID: 26003521      PMCID: PMC4554800          DOI: 10.1016/j.freeradbiomed.2015.05.020

Source DB:  PubMed          Journal:  Free Radic Biol Med        ISSN: 0891-5849            Impact factor:   7.376


  65 in total

1.  A 10-year national trend study of alcohol consumption, 1984-1995: is the period of declining drinking over?

Authors:  T K Greenfield; L T Midanik; J D Rogers
Journal:  Am J Public Health       Date:  2000-01       Impact factor: 9.308

Review 2.  Alcoholic liver disease.

Authors:  Robert S O'Shea; Srinivasan Dasarathy; Arthur J McCullough
Journal:  Hepatology       Date:  2010-01       Impact factor: 17.425

Review 3.  Alcoholic hepatitis.

Authors:  Michael R Lucey; Philippe Mathurin; Timothy R Morgan
Journal:  N Engl J Med       Date:  2009-06-25       Impact factor: 91.245

Review 4.  Bioactive oxidatively truncated phospholipids in inflammation and apoptosis: formation, targets, and inactivation.

Authors:  Thomas M McIntyre
Journal:  Biochim Biophys Acta       Date:  2012-03-16

5.  Human plasma platelet-activating factor acetylhydrolase. Oxidatively fragmented phospholipids as substrates.

Authors:  K E Stremler; D M Stafforini; S M Prescott; T M McIntyre
Journal:  J Biol Chem       Date:  1991-06-15       Impact factor: 5.157

6.  Leukocytes utilize myeloperoxidase-generated nitrating intermediates as physiological catalysts for the generation of biologically active oxidized lipids and sterols in serum.

Authors:  D Schmitt; Z Shen; R Zhang; S M Colles; W Wu; R G Salomon; Y Chen; G M Chisolm; S L Hazen
Journal:  Biochemistry       Date:  1999-12-21       Impact factor: 3.162

Review 7.  Myeloperoxidase: a front-line defender against phagocytosed microorganisms.

Authors:  Seymour J Klebanoff; Anthony J Kettle; Henry Rosen; Christine C Winterbourn; William M Nauseef
Journal:  J Leukoc Biol       Date:  2012-10-11       Impact factor: 4.962

8.  The vascular distribution of the platelet-activating factor receptor.

Authors:  D Predescu; K Ihida; S Predescu; G E Palade
Journal:  Eur J Cell Biol       Date:  1996-01       Impact factor: 4.492

9.  Taurine: protective properties against ethanol-induced hepatic steatosis and lipid peroxidation during chronic ethanol consumption in rats.

Authors:  M D Kerai; C J Waterfield; S H Kenyon; D S Asker; J A Timbrell
Journal:  Amino Acids       Date:  1998       Impact factor: 3.520

10.  The impact of CYP2E1 on the development of alcoholic liver disease as studied in a transgenic mouse model.

Authors:  Angelica Butura; Kerstin Nilsson; Kengathevy Morgan; Timothy R Morgan; Samuel W French; Inger Johansson; Ina Schuppe-Koistinen; Magnus Ingelman-Sundberg
Journal:  J Hepatol       Date:  2008-12-25       Impact factor: 25.083

View more
  11 in total

1.  Enhanced Platelet-Activating Factor Synthesis Facilitates Acute and Delayed Effects of Ethanol-Intoxicated Thermal Burn Injury.

Authors:  Kathleen A Harrison; Eric Romer; Jonathan Weyerbacher; Jesus A Ocana; Ravi P Sahu; Robert C Murphy; Lisa E Kelly; Townsend A Smith; Christine M Rapp; Christina Borchers; David R Cool; Gengxin Li; Richard Simman; Jeffrey B Travers
Journal:  J Invest Dermatol       Date:  2018-05-30       Impact factor: 8.551

Review 2.  Redox (phospho)lipidomics of signaling in inflammation and programmed cell death.

Authors:  Yulia Y Tyurina; Claudette M St Croix; Simon C Watkins; Alan M Watson; Michael W Epperly; Tamil S Anthonymuthu; Elena R Kisin; Irina I Vlasova; Olga Krysko; Dmitri V Krysko; Alexandr A Kapralov; Haider H Dar; Vladimir A Tyurin; Andrew A Amoscato; Elena N Popova; Sergey B Bolevich; Peter S Timashev; John A Kellum; Sally E Wenzel; Rama K Mallampalli; Joel S Greenberger; Hulya Bayir; Anna A Shvedova; Valerian E Kagan
Journal:  J Leukoc Biol       Date:  2019-05-09       Impact factor: 4.962

3.  Causal effect of alcohol use on the risk of end-stage kidney disease and related comorbidities: a Mendelian randomization study.

Authors:  Sehoon Park; Soojin Lee; Yaerim Kim; Yeonhee Lee; Min Woo Kang; Kwangsoo Kim; Yong Chul Kim; Seung Seok Han; Hajeong Lee; Jung Pyo Lee; Kwon Wook Joo; Chun Soo Lim; Yon Su Kim; Dong Ki Kim
Journal:  Kidney Res Clin Pract       Date:  2021-04-20

4.  Inflammatory PAF Receptor Signaling Initiates Hedgehog Signaling and Kidney Fibrogenesis During Ethanol Consumption.

Authors:  Calivarathan Latchoumycandane; Mohamad Hanouneh; Laura E Nagy; Thomas M McIntyre
Journal:  PLoS One       Date:  2015-12-31       Impact factor: 3.240

5.  Schisantherin A alleviated alcohol-induced liver injury by the regulation of alcohol metabolism and NF-kB pathway.

Authors:  Bin Li; Dongnan Li; Yuehua Wang; Xianjun Meng; Xiyun Sun; Jinlong Tian; Lin Shi; Fengming Ma
Journal:  Exp Anim       Date:  2018-05-25

6.  Chronic ethanol ingestion induces glomerular filtration barrier proteins genes expression alteration and increases matrix metalloproteinases activity in the kidney of rats.

Authors:  Mahrokh Samadi; Alireza Shirpoor; Ali Taghizadeh Afshari; Fatemeh Kheradmand; Yousef Rasmi; Maryam Sadeghzadeh
Journal:  Interv Med Appl Sci       Date:  2018-09

7.  Deoxysphingolipids and ether-linked diacylglycerols accumulate in the tissues of aged mice.

Authors:  Ayumi Ando; Masahiro Oka; Yoshinori Satomi
Journal:  Cell Biosci       Date:  2019-08-05       Impact factor: 7.133

8.  Alcohol Consumption Can be a "Double-Edged Sword" for Chronic Kidney Disease Patients.

Authors:  Zhenliang Fan; Jie Yun; Shanshan Yu; Qiaorui Yang; Liqun Song
Journal:  Med Sci Monit       Date:  2019-09-20

Review 9.  Alcohol Misuse and Kidney Injury: Epidemiological Evidence and Potential Mechanisms.

Authors:  Zoltan V Varga; Csaba Matyas; Janos Paloczi; Pal Pacher
Journal:  Alcohol Res       Date:  2017

10.  Ameliorative effect of taurine-chloramine in azathioprine-induced testicular damage; a deeper insight into the mechanism of protection.

Authors:  Mona F Schaalan; Basma K Ramadan; Azza H Abd Elwahab
Journal:  BMC Complement Altern Med       Date:  2018-09-17       Impact factor: 3.659

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.